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TuberculosisAbstract Background: Vitamin D is a potent immunomodulator of innate immune responses, and
its deﬁciency was implicated in the activation of tuberculosis (TB). The effects of vitamin D are
exerted by the interaction with the vitamin D receptor (VDR) and may be inﬂuenced by polymor-
phisms in the VDR gene.
Methods: We conducted a case–control study to identify 25(OH) D levels and FOK1 polymor-
phism of the VDR gene in a group of newly diagnosed pulmonary TB patients and compared to the
ﬁndings in a group of healthy controls.
Results: Obtained results revealed that 25(OH) D levels were signiﬁcantly lower in the patients
than in the controls (P< 0.0001), and the prevalence of vitamin D insufﬁciency was 72.5% in TB
patients. The frequencies of FokI genotypes determined from TB patients were 30% for FF , 50%
for Ff and 20% for ff, while in controls, the frequency of FF, Ff and ff were present in a percentage
of; 40%, 40% and 20%, respectively. There was no signiﬁcant association between the genotype
groups, TB patient and normal control, for FokI polymorphism (P> 0.05). Also, no association
between VDR genotype and 25(OH) D levels was found.
Conclusion: FokI polymorphisms in the VDR gene do not appear to be responsible for host sus-
ceptibility to human tuberculosis in the Egyptian population. However, vitamin D deﬁciency may
be a cause of the susceptibility to tuberculosis.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.
Table 1 Demographic and laboratory ﬁndings in the
participants.
Parameter Control(n= 25) Patients (n= 40)
Age (years) 36 ± 6 35± 8
Male/female 17/8 27/13
25(OH) D (ng/ml) 40.5 ± 4.8 21.4 ± 9.7***
<20 0 (0%) 20 (50%)
P20 and <30 0 (0%) 9 (22.5%)
P30 25 (100%) 11 (27.5%)
Genotype
FF, n (%) 10 (40) 12 (30) (ns)
Ff, n (%) 10 (40) 20 (50) (ns)
ﬀ, n (%) 5 (20) 8 (20) (ns)
*** P< 0.0001, ns; insigniﬁcant difference.
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Pulmonary tuberculosis occurs due to infection of the lungs
with Mycobacterium tuberculosis (MTB). It is a major health
problem throughout the world and remains to be the single
most infectious disease causing high mortality in humans.
Cell mediated immunity can control the infection in most
of the cases [1]. The classic role of vitamin D is the mainte-
nance of bone mineral density; however it has an important
‘‘non-classic’’ inﬂuence on the body’s immune system by
modulating the innate and adaptive immune system and
inﬂuencing the production of important endogenous antimi-
crobial peptides such as cathelicidin and regulating the
inﬂammatory cascade [2]. The plasma 25(OH) D concentra-
tions is a useful vitamin D biomarker because it has a long
half-life in circulation and its concentration is not under
tight homeostatic regulation. This biomarker therefore
reﬂects vitamin D supply and usage over a period of time
[3].
Susceptibility to disease after infection by mycobacteria is
inﬂuenced by environmental and/or host genetic factors. The
interindividual variability of clinical outcome is thought to re-
sult, partially, from variability in the genes that control host
defense. Vitamin D has an immunoregulatory role mediated
by binding to the vitamin D receptor (VDR) in monocytes,
macrophages, and lymphocytes. Vitamin D status seems to
be involved in the development of TB. VDR gene is localized
on the long arm of chromosome 12, and its polymorphisms oc-
curred in several restriction enzyme sites [4]. Cloning of EXON
2 of VDR gene revealed the presence of 2 translation initiation
codons separated apart by 3 codons. Thymine/Cytosine poly-
morphism within the ﬁrst initiation codon results in ACG co-
don. Allelic variants of this polymorphism (rs2228570) were
recognized by FOK I restriction endonuclease [5]. F and f al-
leles have signiﬁcance due to their presence at the translation
initiation codon. VDR coded by F (C nucleotide) is shorter
than VDR f (T nucleotide) by 3 amino-acids [6]. Shorter form
of VDR showed greater transcriptional activation in transfec-
tion experiments [7]. The aim of the present investigation was
to evaluate the vitamin D status and to detect the Fok I single
nucleotide polymorphism (SNP) in the VDR gene of TB
patients.
Materials and methods
Participants
A case–control study involved 40 patients with conﬁrmed pul-
monary TB who were recruited from the Sohag University
Hospital, Sohag, Egypt from June 2013 to December 2013.
M. tuberculosis infection was conﬁrmed by AFB (Acid-Fast
Bacilli) staining in their sputum and by culture. The control
group comprised 25 age and sex matched healthy controls with
no history of TB or other medical problems. Exclusion criteria
were diabetes, hypertension and any other medical problem
that may affect vitamin D level. Informed consent was taken
from all the participants for all procedures and genetic analy-
ses. The study protocol conformed to the tenets of the Helsinki
declaration and it was approved by the institutional research
ethics committee.Blood samples
Fasting venous blood samples (about 3 ml) were taken on
EDTA tubes, centrifuged at 300 rpm for 15 min and the puffy
coat was used for DNA extraction, using spin column extrac-
tion kit supplied by GE Healthcare UK Limited, Cat. No. (28-
9042-66), according to the manufacturer’s instructions. Plasma
samples were used for measuring 25(OH) D, using ELIZA kit,
Cat. No.: REA300/96 (Biovendor products, Germany). Vita-
min D insufﬁciency is considered when 25(OH) D levels are be-
low 30 ng/ml [8].
Fok1 polymorphism
For Fok1 polymorphism, the primers used were 50-AGC-
TGG-CCC-TGG-CAC-TGA-CTC-TGC-TCT-30 and 50-AT
G-GAA-ACA-CCT-TGC-TTC-TTC-TTC-CTC-30. The cy-
cling proﬁle involved denaturation at 94 C for 15 s, annealing
at 55 C for 30 s, and extension at 72 C for 30 s for 35 cycles.
Final extension was continued at 72 C for 10 min. PCR prod-
ucts were digested with Fok 1 restriction endonuclease accord-
ing to the manufacturers instructions. Digested products were
analyzed by electrophoresis in a 2% agarose gel and ethidium
bromide staining. The presence of the Fok 1 restriction site on
both alleles (ff) generates 196- and 69-bp fragments, whereas
the absence (FF) yields one undigested 265-bp fragment. Het-
erozygous Ff exhibits fragments of 265, 196, and 69 bp [4].
Statistical analysis
For 25(OH) D, the results were expressed as mean ± SD and
t-test and ANOVA test were used to compare the results. The
genotype of VDR was expressed as percentage and the odds
ratio was calculated.
Results
The clinical and demographic characteristics of the study
population are in Table 1. There were no signiﬁcant differences
between cases and controls according to age, sex, but they dif-
fered in other respects, such as civil status, employment status,
and education level. Obtained results revealed that plasma
Table 2 25(OH) D levels in TB patients with different
genotypes.
Genotype FF Ff ﬀ
25(OH) D (ng/ml) 21.8 ± 8 (ns) 20.4 ± 10 (ns) 23.6 ± 12 (ns)
Table 3 25(OH) D levels in TB patients according to gender.
Gender Male Female
25(OH) D (ng/ml) 20.3 ± 10.4 (ns) 23.4 ± 8.5 (ns)
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TB patients, P< 0.0001 (Table 1). 29 out of 40 (72.5 %) of TB
patients had vitamin D insufﬁciency. Using the criteria of
25(OH) D< 30 ng/mL, the prevalence of vitamin D insufﬁ-
ciency was 77.5% in patients with TB, and this prevalence
was signiﬁcantly higher than controls (0 %, P= 0.0001;
Fig. 1). We categorized vitamin D levels as deﬁcient <20 ng/
ml, insufﬁcient (P20 and <30) and sufﬁcient (P30 ng/ml)
[9]. Using the criteria of 25(OH) D <20 ng/mL, the prevalence
of vitamin D deﬁciency was 50% in patients with TB, higher
than in controls (0%, P= 0.0001) (Fig. 2).
Genotyping for VDR showed that the FF genotype was
present in 40% of the controls and 30% of the patients (odd
ratio = 0.64. P= 0.14), the Ff genotype was found in 40%
of the controls and 50% of the patients (odd ratio = 1.5,
P= 0.16) and the ff genotype was found in 20% of both the
patients and the controls. No association was found between
VDR genotype and 25(OH) D levels in TB patients, ANOVA
test was used to compare 25(OH) D levels in the different
genotypes and showed no signiﬁcant difference between the re-
sults (P> 0.05), Table 2. Also, no association was found be-
tween 25(OH) D levels and patient gender (P> 0.05), Table 3.Figure 1 Vitamin D receptor ge
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There is much variability among individuals in the response to
mycobacterial infections, but it is not known why certain peo-
ple develop disease when infected with mycobacteria and oth-
ers remain healthy. Genetic susceptibility has been suggested
as one of the most important explanations for individual riskne and its restriction sites [4].
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been studied as a candidate locus due to genetic polymor-
phisms that affects the activity of the receptor and subsequent
downstream vitamin D-mediated effects. Vitamin D metabo-
lism leads to the activation of macrophages and restricts the
intracellular growth of mycobacteria. This effect of vitamin
D may be inﬂuenced by polymorphisms at three sites (TaqI,
BsmI and FokI) in the vitamin D receptor (VDR) gene [11].
Recent studies have also implicated variation of the vitamin
D receptor (VDR) gene in susceptibility to several diseases,
including hepatitis and tuberculosis [12]. Therefore, we studied
the association between vitamin D deﬁciency, VDR polymor-
phism and susceptibility to pulmonary TB in the Egyptian
population.
Our results revealed that plasma levels of 25(OH) D were
signiﬁcantly higher in controls than in TB patients,
P< 0.0001 (Table 1). 31 out of 40 (77.5%) of TB patients
had vitamin D insufﬁciency. This ﬁnding conﬁrms that vitamin
D deﬁciency, as assessed by 25(OH)D, was a risk factor for
TB. The association between vitamin D and tuberculosis was
ﬁrst reported more than 20 years ago [13]. Subsequent studies
had yielded conﬂicting ﬁndings. A number of studies in Guja-
rat India [14], Indian, Pakistani, Somali, Afghan, Sri Lankan
and African residents in London [15], and African immigrants
living in Australia [13] had shown that TB patients had lower
levels of 25(OH) D and higher prevalence of vitamin D deﬁ-
ciency than non-TB individuals. Other studies in Kenya [16]
and West Africa [17] had also reported that TB patients had
lowered 25(OH) D levels compared to non-TB individuals.
However, there was no signiﬁcant difference in 25(OH) D lev-
els between TB patients and controls in Indonesia [18] and
Hong Kong [19]. The observation of low 25(OH) D levels in
TB patients could be due to nutritional factors, however, this
is unlikely. It is well-known that most (90%) of vitamin D is
synthesized in the skin under the inﬂuence of ultraviolet sun-
light of the sun, and only 10% of vitamin D is obtained from
food, mainly salmon, cod ﬁsh, and dairy products. The rela-
tionship between vitamin D and tuberculosis may be mediated
through two mechanisms: increased production of cathelicidin
and enhancement of macrophage ability. 1, 25(OH) 2D, the ac-
tive form of vitamin D, may enhance the production of LL-37,
one of the class of defensins-antimicrobial peptides of the cath-
elicidin family, culminating in TB destruction [20,21]. Further-
more, vitamin D also restricts intracellular growth of TB via
enhancement of macrophage ability. Avoidance of phago-lyso-
some fusion within the macrophage constitutes a key survival
mechanism of TB. The ability of mycobacteria to hinder phag-
osomal progression, a condition known as phagosome matura-
tion arrest [22], is partly achieved via its retention of the host’s
tryptophan-aspartate-containing coat protein (TACO/coro-
nin-1) [23]. Taken together, these data seem to suggest that
low vitamin D status is an antecedent risk factor for TB.
The association between vitamin D insufﬁciency and the riskTable 4 The frequencies of FokI polymorphism VDR gene in Egy
FokI FF (%) Ff (%)
Egyptian 12 (30) 20 (50)
Korean 30 (29.13) 58 (56.31)
European 40 (49.66) 52 (46.55)
African 56 (46.34) 38 (43.45)of tuberculosis suggests that supplementation of vitamin D
may help prevent and reduce the severity of tuberculosis.
Genotyping for FOK1 VDR showed that the FF genotype
was present in 40% of the controls and 30% of the patients
(odd ratio = 0.64. P= 0.14), the Ff genotype was found in
40% of the controls and 50% of the patients (odd ratio = 1.5,
P= 0.16) and the ff genotype was found in 20% of both the
patients and the controls. No association was found between
VDR genotype and 25(OH) D levels in TB patients, ANOVA
test was used to compare 25(OH) D levels in the different
genotypes and showed no signiﬁcant difference between the
results (P> 0.05), Table 2. Also, no association was found be-
tween 25(OH) D levels and patient gender (P> 0.05). How-
ever, we found the differences of genotype frequencies of
FokI VDR between patients from Egypt and the other coun-
tries including Europeans, Africans, and Asians previously re-
ported (Table 4). However it is uncertain if there are racial
differences involved in environmental or genetic factors.
In 2005, Lewis et al. performed a meta-analysis to assess the
association of pulmonary TB with VDR FokI and TaqI poly-
morphisms [24]. In 2006, Yang and Han summarized the asso-
ciation speciﬁcally for VDR FokI polymorphism [25]. Neither
of the studies found a signiﬁcant relationship between VDR
polymorphisms and TB susceptibility. In a previous meta-anal-
ysis of 23 eligible studies, heterogeneous results were observed,
which may be partly explained by the differences between pop-
ulations. Among Asians, the FokI ff genotype showed a pro-
nounced positive association (OR 2.0, 95%CI 1.3–3.2), a
signiﬁcant inverse association was observed for the BsmI bb
genotype (OR 0.5, 95%CI 0.4–0.8), and marginal signiﬁcant
associations were found for TaqI and ApaI polymorphisms.
However, none of the polymorphisms was signiﬁcantly related
to TB among Africans or South Americans [26]. There are two
main possible explanations for the heterogeneity observed in
previous studies. First, the potential inﬂuence of pertinent
environmental factors on different populations may play a role
in determining susceptibility to TB [27]. Exposure to sunlight
and dietary factors, which can inﬂuence serum vitamin D con-
centrations, are the most plausible effect modiﬁers. Another
explanation is the diversity of genetic background in different
populations. It has been reported that genotype frequencies of
VDR polymorphisms differ between populations and may
contribute to inconsistent associations with disease develop-
ment [28].
In conclusion, our ﬁndings support the hypothesis that vita-
min D deﬁciency plays a role as a risk factor for TB, and fur-
ther studies are needed to clarify the potential underlying
mechanisms. Although, VDR polymorphism may be of immu-
noregulatory importance for many disease processes, FokI
polymorphisms in the VDR gene do not appear to be respon-
sible for host susceptibility to human tuberculosis in the Egyp-
tian population. Further studies will be required to investigate
how VDR polymorphism may inﬂuence susceptibility to TB.pt and the other countries.
ﬀ (%) Total (%) Reference
8 (20) 40 (100) In this study
15 (14.56) 103 (100) [4]
13 (8.79) 105 (100) [10]
4 (8.21) 98 (100) [10]
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